The Effect of Metabolites on the Antitoxoplasmic Action of Pyrimethamine and Sulfadiazine
Don E. Eyles, Nell Coleman
Abstract
Don E. Eyles, Nell Coleman
Abstract
SummaryStudies of the inhibition by various metabolites of the antitoxoplasmic action of pyrimethamine and sulfadiazine in acute mouse toxoplasmosis, alone and in combination, resulted in the following findings: 1. p-Aminobenzoic acid completely antagonized the effect of sulfadiazine and partially antagonized the effect of pyrimethamine. It also partially inhibited the effect of the drugs in combination. 2. Folic acid incompletely antagonized the effect of sulfadiazine, but did not antagonize the effect of pyrimethamine. It also had no effect upon the drugs when given in combination. 3. Folinic acid did not materially antagonize the action of the combination of pyrimethamine and sulfadiazine or of the drugs individually.
OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
SummaryStudies of the inhibition by various metabolites of the antitoxoplasmic action of pyrimethamine and sulfadiazine in acute mouse toxoplasmosis, alone and in combination, resulted in the following findings: 1. p-Aminobenzoic acid completely antagonized the effect of sulfadiazine and partially antagonized the effect of pyrimethamine. It also partially inhibited the effect of the drugs in combination. 2. Folic acid incompletely antagonized the effect of sulfadiazine, but did not antagonize the effect of pyrimethamine. It also had no effect upon the drugs when given in combination. 3. Folinic acid did not materially antagonize the action of the combination of pyrimethamine and sulfadiazine or of the drugs individually.
Key concepts: Sulfadiazine, Pyrimethamine, Folinic acid, Pharmacology, Sulfanilamide, Folic Acid Antagonists, Toxoplasmosis, Folic acid